Log in

Relevant bibliographies by topics / Donor/recipient / Journal articles

To see the other types of publications on this topic, follow the link: Donor/recipient.

Journal articles on the topic 'Donor/recipient'

Author: Grafiati

Published: 4 June 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Donor/recipient.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Goldfarb, David A. "Laparoscopic Donor Nephrectomy : Recipient Surgeon's Perspective." Japanese Journal of Urology 96, no. 2 (2005): 49–51. http://dx.doi.org/10.5980/jpnjurol.96.49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Vella, John P., and Alexander C. Wiseman. "Overcoming Donor/Recipient Incompatibility." Nephrology Self-Assessment Program 18, no. 5 (2019): 293–96. http://dx.doi.org/10.1681/nsap.2019.18.5.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lepeytre, Fanny, Catherine Delmas-Frenette, Xun Zhang, et al. "Donor Age, Donor-Recipient Size Mismatch, and Kidney Graft Survival." Clinical Journal of the American Society of Nephrology 15, no. 10 (2020): 1455–63. http://dx.doi.org/10.2215/cjn.02310220.

Full text

Abstract:

Background and objectivesSmall donor and/or kidney sizes relative to recipient size are associated with a higher risk of kidney allograft failure. Donor and recipient ages are associated with graft survival and may modulate the relationship between size mismatch and the latter. The aim of this study was to determine whether the association between donor-recipient size mismatch and graft survival differs by donor and recipient age.Design, setting, participants, & measurementWe performed a retrospective cohort study of first adult deceased donor kidney transplantations performed between 2000

APA, Harvard, Vancouver, ISO, and other styles

4

Godinho, I., J. Guerra, M. J. Melo, et al. "Living-Donor Kidney Transplantation: Donor-Recipient Function Correlation." Transplantation Proceedings 50, no. 3 (2018): 719–22. http://dx.doi.org/10.1016/j.transproceed.2018.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ratner, Lloyd. "Surgical Techniques: Donor and Recipient." Journal of Vascular and Interventional Radiology 13, no. 2 (2002): P37. http://dx.doi.org/10.1016/s1051-0443(02)70030-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Goldman, M. "Donor selection for recipient safety." ISBT Science Series 8, no. 1 (2013): 54–57. http://dx.doi.org/10.1111/voxs.12007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Valk, Sarah J., Camila Caram‐Deelder, Jaap Jan Zwaginga, Johanna G. Bom, and Rutger A. Middelburg. "Donor sex and recipient outcomes." ISBT Science Series 15, no. 1 (2019): 142–50. http://dx.doi.org/10.1111/voxs.12528.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Streem, Stevan B., Andrew C. Novick, Donald R. Steinmuller, and Donna Graneto. "Flank Donor Nephrectomy: Efficacy in the Donor and Recipient." Journal of Urology 141, no. 5 (1989): 1099–101. http://dx.doi.org/10.1016/s0022-5347(17)41181-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Koffron, A., C. Herman, O. Gross, et al. "Laparoscopic donor nephrectomy: analysis of donor and recipient outcomes." Transplantation Proceedings 33, no. 1-2 (2001): 1111. http://dx.doi.org/10.1016/s0041-1345(00)02437-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sauer, P. "Living-donor liver transplantation: evaluation of donor and recipient." Nephrology Dialysis Transplantation 19, suppl_4 (2004): iv11—iv15. http://dx.doi.org/10.1093/ndt/gfh1035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pirsch, J. D., H. M. Nelson, A. M. D'Alessandro, et al. "LIVING-UNRELATED RENAL DONOR TRANSPLANTS: DONOR AND RECIPIENT ATTITUDES." Transplantation 65, Supplement (1998): 218. http://dx.doi.org/10.1097/00007890-199805131-00557.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pirsch, J. D., H. M. Nelson, A. M. D'Alessandro, et al. "LIVING-UNRELATED RENAL DONOR TRANSPLANTS: DONOR AND RECIPIENT ATTITUDES." Transplantation 65, no. 12 (1998): S142. http://dx.doi.org/10.1097/00007890-199806270-00578.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Malone, Andrew F., Haojia Wu, Catrina Fronick, Robert Fulton, Joseph P. Gaut, and Benjamin D. Humphreys. "Harnessing Expressed Single Nucleotide Variation and Single Cell RNA Sequencing To Define Immune Cell Chimerism in the Rejecting Kidney Transplant." Journal of the American Society of Nephrology 31, no. 9 (2020): 1977–86. http://dx.doi.org/10.1681/asn.2020030326.

Full text

Abstract:

BackgroundIn solid organ transplantation, donor-derived immune cells are assumed to decline with time after surgery. Whether donor leukocytes persist within kidney transplants or play any role in rejection is unknown, however, in part because of limited techniques for distinguishing recipient from donor cells.MethodsWhole-exome sequencing of donor and recipient DNA and single-cell RNA sequencing (scRNA-seq) of five human kidney transplant biopsy cores distinguished immune cell contributions from both participants. DNA-sequence comparisons used single nucleotide variants (SNVs) identified in th

APA, Harvard, Vancouver, ISO, and other styles

14

Ratner, Lloyd E. "LAPAROSCOPIC LIVE DONOR NEPHRECTOMY: THE RECIPIENT." Transplantation 72, no. 2 (2001): 356–57. http://dx.doi.org/10.1097/00007890-200107270-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Oprzędkiewicz, Aleksandra, Hubert Mado, Wioletta Szczurek, Mariusz Gąsior, and Bożena Szyguła-Jurkiewicz. "Donor-recipient Matching in Heart Transplantation." Open Cardiovascular Medicine Journal 14, no. 1 (2020): 42–47. http://dx.doi.org/10.2174/18741924020140100042.

Full text

Abstract:

Heart transplantation remains the treatment of choice for end-stage Heart Failure (HF). Due to the shortage of organs for transplantation and the occurrence of perioperative complications, a key problem is donor matching, which should result in increased survival and improved quality of life for patients. The success of this procedure depends on various parameters such as gender, weight, ABO blood group and Human Leukocyte Antigen (HLA) system of both the recipient and the donor. Furthermore, non-HLA antigens may also be valuable in donor-recipient matching. The aim of this article is to summa

APA, Harvard, Vancouver, ISO, and other styles

16

Avolio, A. W., S. Agnes, and M. Castagneto. "Ethical implications in donor–recipient allocation." Transplantation Proceedings 32, no. 1 (2000): 81–82. http://dx.doi.org/10.1016/s0041-1345(99)00886-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Fettouh, H. A., H. A. Raouf, A. el Shenoufy, et al. "Laparoscopic Donor Nephrectomy for Pediatric Recipient." Transplantation Proceedings 39, no. 4 (2007): 811–12. http://dx.doi.org/10.1016/j.transproceed.2007.03.073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

STEEN, G. J. V. D., and J. D'AMARO. "Computer Selection of Donor-Recipient Pairs." Tissue Antigens 2, no. 3 (2008): 189–95. http://dx.doi.org/10.1111/j.1399-0039.1972.tb00135.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Starzl, Thomas E., Abdul S. Rao, Angus W. Thomson, Noriko Murase, and Anthony J. Demetris. "DONOR-RECIPIENT MICROCHIMERISM AND TOLERANCE INDUCTION." Transplantation 61, no. 1 (1996): 169170. http://dx.doi.org/10.1097/00007890-199601150-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Ratner, L. E., R. A. Montgomery, C. Cohen, et al. "LAPAROSCOPIC LIVE DONOR NEPHRECTOMY: THE RECIPIENT." Transplantation 65, Supplement (1998): 185. http://dx.doi.org/10.1097/00007890-199805131-00426.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ratner, L. E., R. A. Montgomery, C. Cohen, et al. "LAPAROSCOPIC LIVE DONOR NEPHRECTOMY: THE RECIPIENT." Transplantation 65, no. 12 (1998): S109. http://dx.doi.org/10.1097/00007890-199806270-00447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Briceño, Javier, Ruben Ciria, and Manuel de la Mata. "Donor-recipient matching: Myths and realities." Journal of Hepatology 58, no. 4 (2013): 811–20. http://dx.doi.org/10.1016/j.jhep.2012.10.020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Bitterman, D. S., C. V. Levens, and I. N. Cholst. "Does donor age affect recipient outcomes?" Fertility and Sterility 98, no. 3 (2012): S50. http://dx.doi.org/10.1016/j.fertnstert.2012.07.182.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Ravi, Y., N. Srikanth, I. W. Paul, B. A. Whitson, S. Emani, and C. B. Sai-Sudhakar. "Heart Transplant Recipient and Donor Age: Should the Younger Recipient Be Matched with the Younger Donor?" Journal of Heart and Lung Transplantation 38, no. 4 (2019): S161—S162. http://dx.doi.org/10.1016/j.healun.2019.01.386.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Spatenka, J., T. Seeman, E. Foltynova, et al. "Effect of donor/recipient body weight ratio, donor weight, recipient weight and donor age on kidney graft function in children." Nephrology Dialysis Transplantation 27, no. 2 (2011): 820–24. http://dx.doi.org/10.1093/ndt/gfr319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Sarnicola, Enrica, Caterina Sarnicola, Albert Y. Cheung, Edoardo Panico, Claudio Panico, and Vincenzo Sarnicola. "Total or subtotal full thickness recipient bed cut to repair donor–recipient curvature disparity in cases of DM rupture with manual DALK." European Journal of Ophthalmology 30, no. 5 (2020): 1172–78. http://dx.doi.org/10.1177/1120672120932833.

Full text

Abstract:

Purpose: To report how to manage a specific type of Descemet’s membrane (DM) rupture during manual DALK with a concurrent donor–recipient disparity of curvature. Methods: Case report of two patients that had DM rupture during manual DALK with a concurrent donor–recipient disparity of curvature; the recipient bed was flatter (post-infectious scar, case 1) and steeper (keratoglobus, case 2) than the donor. Preoperative diagnosis, clinical exam, and best spectacle correct visual acuity (BSCVA) have been reported. A subtotal full-thickness circular cut of the recipient bed was performed to resolve

APA, Harvard, Vancouver, ISO, and other styles

27

Beal, Eliza W., Dmitry Tumin, Lanla F. Conteh, et al. "Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect." Journal of Transplantation 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/9709430.

Full text

Abstract:

There is a paucity of literature examining recipient-donor obesity matching on liver transplantation outcomes. The United Network for Organ Sharing database was queried for first-time recipients of liver transplant whose age was ≥18 between January 2003 and September 2013. Outcomes including patient and graft survival at 30 days, 1 year, and 5 years and overall, liver retransplantation, and length of stay were compared between nonobese recipients receiving a graft from nonobese donors and obese recipient-obese donor, obese recipient-nonobese donor, and nonobese recipient-obese donor pairs. 51,

APA, Harvard, Vancouver, ISO, and other styles

28

Khamaganova, E. G., and L. A. Kuzmina. "ASSESSMENT OF HLA-COMPATIBILITY AND REQUIREMENTS FOR HLA-TYPING OF PATIENT AND DONOR IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION." Russian journal of hematology and transfusiology 64, no. 2 (2019): 175–87. http://dx.doi.org/10.35754/0234-5730-2019-64-2-175-187.

Full text

Abstract:

Introduction. Unification of guidelines and standards concerning requirements for HLA typing and assessment of the degree of HLA match between the recipient and the donor for different types of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is of a great importance.Aim. To present contemporary requirements for the HLA typing of a recipient and a donor for allo-HSCT, to generalize recom mendations for assessing a required match degree of a recipient and a donor and to provide data on additional immunogenetic factors capable of improving the results of allogeneic hematopoietic st

APA, Harvard, Vancouver, ISO, and other styles

29

Movsum Huseynli, Nargiz. "The concept of donor and recipient and their legal status." SCIENTIFIC WORK 61, no. 12 (2020): 129–32. http://dx.doi.org/10.36719/2663-4619/61/129-132.

Full text

Abstract:

In the field of transplantation of human organs and tissues, the donor is a person who voluntarily donates his organs and tissues to transplant patients, and the recipient is a person who transplants organs and tissues for therapeutic purposes. It should be noted that if the donor is under 18 years of age, it is not allowed to remove organs and tissues for transplantation purposes, except for bone marrow. Also, the medical decision on transplantation is made directly to the recipient, if the recipient is considered to be under 18 years of age and legally incapable, then the information is pass

APA, Harvard, Vancouver, ISO, and other styles

30

Palin, Niina K., Johanna Savikko, Jukka M. Rintala, and Petri K. Koskinen. "Intensive Perioperative Simvastatin Treatment Protects from Chronic Kidney Allograft Injury." American Journal of Nephrology 41, no. 4-5 (2015): 383–91. http://dx.doi.org/10.1159/000431338.

Full text

Abstract:

Background/Aims: Ischemia-reperfusion injury (IRI) and innate immune response augment adaptive immunity and may also trigger repair processes that lead to uncontrolled fibrosis and atherosclerosis as seen in chronic allograft injury. Simvastatin has been shown to protect from renal IRI in several experimental studies. The aim of this study was to examine the effect of donor simvastatin pretreatment and early initiation of recipient simvastatin treatment on chronic kidney allograft injury. Methods: A rat renal transplantation model was used. Simvastatin was administered perorally for donor (5 m

APA, Harvard, Vancouver, ISO, and other styles

31

Lucey, Michael R. "Living Donor Liver Transplantation: Balancing Donor Risk with Recipient Need." Graft 4, no. 3 (2001): 223–24. http://dx.doi.org/10.1177/152216280100400310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Andrews, P. A., F. Compton, and C. G. Koffman. "Influence of donor/recipient size in living donor kidney transplantation." Transplantation Proceedings 33, no. 1-2 (2001): 1146–47. http://dx.doi.org/10.1016/s0041-1345(00)02465-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Humar, Abhinav. "Donor and recipient outcomes after adult living donor liver transplantation." Liver Transplantation 9, no. 10C (2003): S42—S44. http://dx.doi.org/10.1053/jlts.2003.50219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Lindler, Tekisha U., Justin D. Mclarty, Gregory R. Lamberton, et al. "DONOR SMOKING NEGATIVELY IMPACTS LIVING DONOR AND RECIPIENT RENAL FUNCTION." Journal of Urology 179, no. 4S (2008): 693–94. http://dx.doi.org/10.1016/s0022-5347(08)62024-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Srinivasan, A., D. York, P. Ranganathan, et al. "Transfusion-associated AIDS: donor-recipient human immunodeficiency virus exhibits genetic heterogeneity." Blood 69, no. 6 (1987): 1766–70. http://dx.doi.org/10.1182/blood.v69.6.1766.1766.

Full text

Abstract:

Abstract The genetic diversity of the human immunodeficiency virus (HIV) isolated from transfusion-associated AIDS patients has been examined. Restriction enzyme mapping studies of integrated proviral DNA of donor and recipient origin demonstrated genomic variation between isolates. Analysis of the molecularly cloned viral genomes of one donor-recipient pair showed that virus from the recipient had restriction enzyme site differences from the donor, noticeably clustered in the env and orf-2 regions, and also had a greater number of restriction sites in common with the donor as well. These resu

APA, Harvard, Vancouver, ISO, and other styles

36

Srinivasan, A., D. York, P. Ranganathan, et al. "Transfusion-associated AIDS: donor-recipient human immunodeficiency virus exhibits genetic heterogeneity." Blood 69, no. 6 (1987): 1766–70. http://dx.doi.org/10.1182/blood.v69.6.1766.bloodjournal6961766.

Full text

Abstract:

The genetic diversity of the human immunodeficiency virus (HIV) isolated from transfusion-associated AIDS patients has been examined. Restriction enzyme mapping studies of integrated proviral DNA of donor and recipient origin demonstrated genomic variation between isolates. Analysis of the molecularly cloned viral genomes of one donor-recipient pair showed that virus from the recipient had restriction enzyme site differences from the donor, noticeably clustered in the env and orf-2 regions, and also had a greater number of restriction sites in common with the donor as well. These results sugge

APA, Harvard, Vancouver, ISO, and other styles

37

Sonnenberg, FA, MH Eckman, and SG Pauker. "Bone marrow donor registries: the relation between registry size and probability of finding complete and partial matches [see comments]." Blood 74, no. 7 (1989): 2569–78. http://dx.doi.org/10.1182/blood.v74.7.2569.2569.

Full text

Abstract:

Abstract In a registry of volunteer bone marrow donors, the relation between registry size and probability of finding an exact or partial match for a random recipient cannot be theoretically derived because it depends on specifics of the human leukocyte antigen (HLA) haplotype frequencies in the donor and recipient populations. The relation must be explicitly calculated using empirically determined HLA haplotype frequency data for all possible pairings between a donor and a recipient population. This report describes a general solution to this problem. The method shows that the relation of the

APA, Harvard, Vancouver, ISO, and other styles

38

Sonnenberg, FA, MH Eckman, and SG Pauker. "Bone marrow donor registries: the relation between registry size and probability of finding complete and partial matches [see comments]." Blood 74, no. 7 (1989): 2569–78. http://dx.doi.org/10.1182/blood.v74.7.2569.bloodjournal7472569.

Full text

Abstract:

In a registry of volunteer bone marrow donors, the relation between registry size and probability of finding an exact or partial match for a random recipient cannot be theoretically derived because it depends on specifics of the human leukocyte antigen (HLA) haplotype frequencies in the donor and recipient populations. The relation must be explicitly calculated using empirically determined HLA haplotype frequency data for all possible pairings between a donor and a recipient population. This report describes a general solution to this problem. The method shows that the relation of the probabil

APA, Harvard, Vancouver, ISO, and other styles

39

Fast, Loren D. "Recipient elimination of allogeneic lymphoid cells: donor CD4+ cells are effective alloantigen-presenting cells." Blood 96, no. 3 (2000): 1144–49. http://dx.doi.org/10.1182/blood.v96.3.1144.

Full text

Abstract:

Abstract The encounter with allogeneic major histocompatibility complex (MHC) molecules expressed on donor leukocytes during transfusion of blood products has been shown to impact the recipient's immune responses in a number of settings. To better understand the responses induced by the transfer of allogeneic cells, a murine model was used to characterize the recipient responses that control the fate of the allogeneic lymphoid cells. Recipient CD8+ cells could rapidly eliminate a large number of donor cells within 3 days after injection. When elimination responses were studied in the absence o

APA, Harvard, Vancouver, ISO, and other styles

40

Fast, Loren D. "Recipient elimination of allogeneic lymphoid cells: donor CD4+ cells are effective alloantigen-presenting cells." Blood 96, no. 3 (2000): 1144–49. http://dx.doi.org/10.1182/blood.v96.3.1144.015k46_1144_1149.

Full text

Abstract:

The encounter with allogeneic major histocompatibility complex (MHC) molecules expressed on donor leukocytes during transfusion of blood products has been shown to impact the recipient's immune responses in a number of settings. To better understand the responses induced by the transfer of allogeneic cells, a murine model was used to characterize the recipient responses that control the fate of the allogeneic lymphoid cells. Recipient CD8+ cells could rapidly eliminate a large number of donor cells within 3 days after injection. When elimination responses were studied in the absence of CD8+ ce

APA, Harvard, Vancouver, ISO, and other styles

41

Capello, Daniela, Giuliana Muti, Michaela Cerri, et al. "Molecular Analysis of Posttransplant Lymphoproliferative Disorders (PTLD) of Donor Origin Occuring in Liver Transplant Patients." Blood 106, no. 11 (2005): 1916. http://dx.doi.org/10.1182/blood.v106.11.1916.1916.

Full text

Abstract:

Abstract Most PTLD occurring in solid organ patients arise from recipient cells, whereas few cases derive from donor transplanted lymphocytes. Donor-derived PTLD usually have a predilection for the allograft and are particularly frequent following liver transplant. To clarify the histogenesis and pathogenesis of donor-derived PTLD, we investigated 11 monoclonal PTLD occurring in liver transplant patients, including 6 cases arising from donor cells and 5 cases from recipient cells. Phenotypic markers of histogenesis included expression of BCL6, MUM1 and CD138, which segregate the germinal cente

APA, Harvard, Vancouver, ISO, and other styles

42

Whitson, B. A., Y. Ravi, S. Emani, et al. "Heart Transplant Recipient and Donor Age Mismatching: Should the Older Recipient Be Paired with the Older Donor?" Journal of Heart and Lung Transplantation 33, no. 4 (2014): S163. http://dx.doi.org/10.1016/j.healun.2014.01.437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Fast, LD, CR Valeri, and JP Crowley. "Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease." Blood 86, no. 8 (1995): 3090–96. http://dx.doi.org/10.1182/blood.v86.8.3090.3090.

Full text

Abstract:

Abstract Graft-versus-host disease (GVHD) is currently encountered after bone marrow transplantation and transfusion. GVHD associated with transfusion (TA-GVHD) in apparently immunocompetent recipients has been recently reported with increasing frequency. A consistent finding in many of these cases is that the recipient received blood from a donor homozygous for one of the recipient's HLA haplotypes. However, the observed frequency of TA-GVHD is much lower than the estimated probability of this donor/recipient combination. The potential role of recipient immune responses in controlling TA-GVHD

APA, Harvard, Vancouver, ISO, and other styles

44

Fast, LD, CR Valeri, and JP Crowley. "Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease." Blood 86, no. 8 (1995): 3090–96. http://dx.doi.org/10.1182/blood.v86.8.3090.bloodjournal8683090.

Full text

Abstract:

Graft-versus-host disease (GVHD) is currently encountered after bone marrow transplantation and transfusion. GVHD associated with transfusion (TA-GVHD) in apparently immunocompetent recipients has been recently reported with increasing frequency. A consistent finding in many of these cases is that the recipient received blood from a donor homozygous for one of the recipient's HLA haplotypes. However, the observed frequency of TA-GVHD is much lower than the estimated probability of this donor/recipient combination. The potential role of recipient immune responses in controlling TA-GVHD was inve

APA, Harvard, Vancouver, ISO, and other styles

45

Poldervaart, Rosalie A., Mirjam Laging, Tessa Royaards, et al. "Alternative Living Kidney Donation Programs Boost Genetically Unrelated Donation." Journal of Transplantation 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/748102.

Full text

Abstract:

Donor-recipient ABO and/or HLA incompatibility used to lead to donor decline. Development of alternative transplantation programs enabled transplantation of incompatible couples. How did that influence couple characteristics? Between 2000 and 2014, 1232 living donor transplantations have been performed. In conventional and ABO-incompatible transplantation the willing donor becomes an actual donor for the intended recipient. In kidney-exchange and domino-donation the donor donates indirectly to the intended recipient. The relationship between the donor and intended recipient was studied. There

APA, Harvard, Vancouver, ISO, and other styles

46

Heldt, Jonathan, Robert Torrey, Daniel Han, et al. "Donor Smoking Negatively Affects Donor and Recipient Renal Function following Living Donor Nephrectomy." Advances in Urology 2011 (2011): 1–5. http://dx.doi.org/10.1155/2011/929263.

Full text

Abstract:

Background.While tobacco use by a renal transplant recipient has been shown to negatively affect graft and patient survival, the effect of smoking on the part of the kidney donor remains unknown.Methods.29 smoking donors (SD) and their recipients (SD-R) as well as 71 non-smoking donors (ND) and their recipients (ND-R) were retrospectively reviewed. Preoperative demographics and perioperative variables including serum creatinine (Cr) and glomerular filtration rate (GFR) were calculated and stratified by amount of tobacco exposure in pack-years. Clinical outcomes were analyzed with a Student'st-

APA, Harvard, Vancouver, ISO, and other styles

47

Namatevs, Ivars, and Ludmila Aleksejeva. "Decision Algorithm for Heuristic Donor-Recipient Matching." MENDEL 23, no. 1 (2017): 33–40. http://dx.doi.org/10.13164/mendel.2017.1.033.

Full text

Abstract:

This paper introduces the application of artificial intelligence paradigm towards precision medicine in renal transplantation. The match of the optimal donor-recipient pair in kidney transplantation in Latvian Transplant Centre (LTC) has been constrained by the lack of prediction models and algorithms. Consequently, LTC seeks for practical intelligent computing solution to assist the clinical setting decision-makers during their search for the optimal donor-recipient match. Therefore, by optimizing both the donor and recipient profiles, prioritizing importance of the features, and based on gre

APA, Harvard, Vancouver, ISO, and other styles

48

Rong, Rong, Frederic Bibollet-Ruche, Joseph Mulenga, Susan Allen, Jerry L. Blackwell, and Cynthia A. Derdeyn. "Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection." Journal of Virology 81, no. 3 (2006): 1350–59. http://dx.doi.org/10.1128/jvi.01839-06.

Full text

Abstract:

ABSTRACT Biologically functional clade C envelope (Env) glycoproteins from the chronically (donor) and newly (recipient) infected partners of four heterosexual transmission pairs in Zambia were cloned and characterized previously. In each case, the donor viral quasispecies contained Envs that were resistant to autologous neutralization by contemporaneous plasma, while the recipient Envs were sensitive to neutralizing antibodies in this donor plasma sample. The donor Envs also varied in length, glycosylation, and amino acid sequence of the V1V2 hypervariable domain of gp120, while the recipient

APA, Harvard, Vancouver, ISO, and other styles

49

Takami, Akiyoshi, J. Luis Espinoza, Ken Ishiyama та ін. "The FcγRllla Polymorphism Correlates with Chronic Graft-Versus-Host Disease and Treatment Related Mortality." Blood 112, № 11 (2008): 2237. http://dx.doi.org/10.1182/blood.v112.11.2237.2237.

Full text

Abstract:

Abstract The FcγRllla (FCGR3A) 158V/V allotype displays a higher antibody-dependent cellular cytotoxicity compared to the FCGR3A-158V/F or 158F/F allotype, leading to susceptibility to rheumatoid arthritis, better clinical response to rituximab in NHL, and lower risk of periodontitis. We tested the hypothesis that FCGR3A polymorphism influences the development of GVHD and GVL, and TRM. The FCGR3A-158V/F genotype was determined in 49 recipient and donor pairs who underwent HLA-matched SCT in our institute. Subjects with the recipient FCGR3A-158V/V allotype and the donor FCGRA-158V/V allotype we

APA, Harvard, Vancouver, ISO, and other styles

50

Parry, Andrew, and Stephen Large. "Donor-recipient size match in heart transplantation." Journal of Thoracic and Cardiovascular Surgery 108, no. 6 (1994): 1150–51. http://dx.doi.org/10.1016/s0022-5223(94)70165-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!